Status:
COMPLETED
Pulmonary Rehabilitation in Interstitial Lung Diseases
Lead Sponsor:
KU Leuven
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Treatment in interstitial lung diseases (ILD) is frequently ineffective. Pulmonary rehabilitation (PR) is an excellent therapeutic option in another chronic lung diseases such as chronic obstructive p...
Eligibility Criteria
Inclusion
- Diagnosis of interstitial lung disease according to internationally established criteria
- Dyspnea on exertion
- Stable medical therapy
- Stable clinical condition at inclusion, with no infection or exacerbation in the previous 4 weeks
Exclusion
- Co-morbidities that do not allow exercise training (unstable angina, recent myocardial infarction or cerebrovascular accident, active cancer, severe orthopedic disorders).
- Life expectancy below 3 months
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00882817
Start Date
April 1 2009
End Date
November 1 2011
Last Update
August 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholieke Universiteit Leuven
Leuven, Flanders, Belgium, 3000